Arturo Rodríguez
View from the Top
Arturo Rodríguez
Managing Director
Ramboll Mexico
Ramboll Mexico Managing Director Arturo Rodríguez discusses the future of environmental and industrial safety in the "new normal".
Mexico’s Opportunities And Challenges As A Research Hub
Analysis
What is Mexico’s potential to become a research hub and how can the country successfully capitalize on this opportunity?
Arturo Rodríguez
View from the Top
Arturo Rodríguez
Principal Consultant and Managing Director
Ramboll
Ramboll's Managing Director advises its clients to put social and environmental considerations at the center of their planning.
Infinite_ArturoRodriguez
View from the Top
Arturo Rodríguez
CEO
Infinite Clinical Research
INFINITE is a 100 percent Mexican institution with 15 years of experience in clinical research in Latin America.
analysis1
Analysis
Minerals are embedded in most aspects of human life. This ensures a steady demand, making mining one of the wealthiest industries in the world. But…
Arturo Rodríguez
Insight
Arturo Rodríguez
CEO
Infinite Clinical Research (ICR)
“As ACROM, we participated in March 2017 in a group of leaders in charge of optimizing response times for the approval of clinical trials.”
MHS 2017
News Article
Mexico Health Summit 2017: Taking Mexico to the Top 10 in Clinical Research panel highlights
Ciro García
Roundtable
Ciro García
Ciro García
Director General
Accelerium Clinical Research

Mexico has strong potential to become a clinical research leader worldwide. We have all the elements, such as population, disease profile, ensemble of trained investigators and the local representation of the international bio-pharmaceutical and CRO industries, as well as the support of COFEPRIS and the most recognized agencies worldwide. However, we need to assimilate all the elements together in the most synergistic manner to significantly elevate the total number of the active trials in the coming years. Research sites should orient their activities to quality and performance to attract more research projects. Mexico accounts for less than 1 percent of all clinical research worldwide, a very low rate compared to other countries.

Mexico Health Review spoke with three CROs about the best strategies that can help Mexico become an international hub for clinical research.
Arturo Rodríguez
View from the Top
Arturo Rodríguez
Director General of ICR and President
ACROM
Infinite Clinical Research (ICR) is a Mexican CRO that has 15 years of experience in clinical trials in Mexico and in Latin America.
Subscribe to Arturo Rodriguez